Entero Therapeutics, Inc.
ENTO
$0.3541
-$0.0241-6.37%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -55.43% | -44.63% | -80.70% | -7.54% | 12.74% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -52.44% | -44.90% | -86.34% | 226.08% | 81.86% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | 0.00% | -- | -- | -- |
Total Current Assets | -0.43% | -0.65% | 1,026.66% | 51.12% | 24.63% |
|
|||||
Total Current Assets | -0.43% | -0.65% | 1,026.66% | 51.12% | 24.63% |
Net Property, Plant & Equipment | -12.19% | -11.47% | -21.28% | -1.33% | -10.14% |
Long-term Investments | 0.00% | 0.00% | -91.60% | 1,089.79% | 0.00% |
Goodwill | 0.00% | 0.00% | -91.60% | 1,089.79% | 0.00% |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -20.03% | 181.05% | -99.92% | 192,073.17% | 0.00% |
Total Assets | -0.48% | -0.54% | -5.32% | 1,224.00% | 16.13% |
|
|||||
Total Accounts Payable | 33.60% | 9.98% | 0.88% | 260.18% | -4.32% |
Total Accrued Expenses | 14.96% | -87.97% | -28.65% | 209.51% | -1.10% |
Short-term Debt | -- | -- | -54.08% | -36.88% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.52% | 2.71% | 8.71% | 6.11% | 2.76% |
Total Finance Division Other Current Liabilities | 84.06% | 16.68% | 869.96% | 8.42% | 7.04% |
Total Other Current Liabilities | 84.06% | 16.68% | 869.96% | 8.42% | 7.04% |
Total Current Liabilities | 75.56% | 1.99% | 149.21% | 97.02% | 26.22% |
|
|||||
Total Current Liabilities | 75.56% | 1.99% | 149.21% | 97.02% | 26.22% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -54.08% | -36.88% | -- |
Capital Leases | -26.43% | -20.59% | -20.85% | -13.14% | -11.51% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 75.04% | 1.84% | 16.70% | 304.54% | 23.86% |
|
|||||
Common Stock & APIC | 0.00% | 0.93% | 0.90% | 3.73% | 2.41% |
Retained Earnings | -6.44% | -1.38% | -4.93% | 3.02% | -2.28% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -146.32% | -8.24% | -43.64% | 349.16% | 9.88% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
|
|||||
Total Common Equity | -146.32% | -8.24% | -43.64% | 349.16% | 9.88% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -17.48% | -1.06% | -9.07% | 2,061.15% | 9.88% |
|